Kiora Pharmaceuticals, Inc. (KPRX) vs Pluri Inc. (PLUR)
A side-by-side comparison of Kiora Pharmaceuticals, Inc. and Pluri Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
KPRX
Kiora Pharmaceuticals, Inc.
$2.51HealthcareDelayed quote: Oct 6, 2026, 3:32 PM EDT
PLUR
Pluri Inc.
$1.03HealthcareDelayed quote: Oct 6, 2026, 3:22 PM EDT
Total return — KPRX vs PLUR
growth of $100 · dividends reinvested · last 10yKPRX -100.0% (-56.0%/yr)PLUR -99.2% (-38.2%/yr)PLUR compounded faster over this window
Log scale — wide-divergence pair
KPRX PLUR
KPRX vs PLUR: by the numbers
- •KPRX is the larger company ($11M vs $11M market cap).
- •Both run net losses; KPRX's is the smaller (0.00% vs -2406.00% net margin).
Metrics side by side
Valuation
| Metric | KPRX | PLUR |
|---|---|---|
| P/S ratio | N/A | 10.89 |
| P/B ratio | 0.66 | N/A |
Profitability
| Metric | KPRX | PLUR |
|---|---|---|
| Gross margin | 0.00% | 44.59% |
| Operating margin | 0.00% | -2455.91% |
| Net margin | 0.00% | -2406.00% |
| ROE | -65.18% | N/A |
| ROIC | -59.42% | -127.37% |
Growth (annualized)
| Metric | KPRX | PLUR |
|---|---|---|
| Total return CAGR (5Y) | -67.06% | -44.78% |
Frequently asked
- How have KPRX and PLUR total returns compared?
- Over the past 10 years, KPRX delivered -55.97% and PLUR delivered -38.09% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.